NotesFAQContact Us
Search Tips
ERIC Number: ED255822
Record Type: Non-Journal
Publication Date: 1985
Pages: 20
Abstractor: N/A
Reference Count: N/A
A Survey of Members of Congress about Drug Abuse in Their Districts. A Report of the Select Committee on Narcotics Abuse and Control. House of Representatives, Ninety-Eighth Congress, Second Session.
Congress of the U.S., Washington, DC. House Select Committee on Narcotics Abuse and Control.
Members of the House of Representatives from 92 districts in 32 states, Puerto Rico, and the District of Columbia (21 percent) responded to a questionnaire soliciting information about the drug abuse situation in their congressional districts. Results from the questionnaire showed that over 96 percent of the respondents characterized drug abuse in their districts as either severe or moderate. The five most prevalent drugs, in order of frequency of mention, were marijuana, cocaine, stimulants, tranquilizers, and hallucinogens. Marijuana was believed to have been grown illicitly in over 60 percent of the reported districts, and illicit drug manufacture was believed to have occurred in nearly half the districts. Schools, streets, and workplaces were seen as the primary locations at which drugs were abused; schools, streets, parks, and public facilities for entertainment and sports were most frequently cited as trafficking locales. Crimes committed by drug users and juvenile behavior problems were most often perceived as the major problems resulting from drug abuse. Respondents stated that their constituents appeared to express the need for better drug abuse prevention/education programs and for improved drug law enforcement and prosecution capabilities. The Select Committee on Narcotics Abuse and Control concluded that intensified efforts by all levels of government, as well as the private sector, are needed to combat drug-related problems. (NRB)
Publication Type: Legal/Legislative/Regulatory Materials; Reports - Research
Education Level: N/A
Audience: N/A
Language: English
Sponsor: N/A
Authoring Institution: Congress of the U.S., Washington, DC. House Select Committee on Narcotics Abuse and Control.